PAXORLEA
Dead / Abandoned — Abandoned — failure to respond (as of 19 Jan 2024)
What this means for you
This application is over — abandoned 22 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97725615
- Mark type
- Stylized text
- Filed
- 20 Dec 2022
- Abandoned
- 22 Dec 2023
- Attorney of record
- Alexander C. Kaczmarek
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Components of pharmaceutical preparations; Pharmaceutical preparations sold as a component of a pharmaceutical product; Pharmaceutical compounds and substances sold as components of pharmaceutical products and preparations for the treatment of cancer; Active pharmaceutical ingredient being a component in pharmaceutical preparations for the treatment of cancer
Owner
- Athenex, Inc., Buffalo, NY, US
Prosecution history
- 19 Jan 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 19 Jan 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 19 Jan 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 21 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Sept 2023 — NON-FINAL ACTION E-MAILED
- 21 Sept 2023 — NON-FINAL ACTION WRITTEN
- 20 Sept 2023 — ASSIGNED TO EXAMINER
- 17 Jan 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Dec 2022 — NEW APPLICATION ENTERED